Endovia Health Sciences, Inc. EDVA
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -6.22% | -50.01% | -19.58% |
| Total Depreciation and Amortization | -- | -- | -20.77% | -6.12% | 11.56% |
| Total Amortization of Deferred Charges | -- | -- | -33.36% | -35.38% | -21.30% |
| Total Other Non-Cash Items | -- | -- | 83.19% | 948.79% | 437.35% |
| Change in Net Operating Assets | -- | -- | -22.44% | -32.95% | -25.38% |
| Cash from Operations | -- | -- | 38.57% | 32.47% | 23.43% |
| Capital Expenditure | -- | -- | -- | 100.00% | -113.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -200.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 100.00% | -- |
| Total Debt Issued | -- | -- | -54.11% | -48.91% | -30.37% |
| Total Debt Repaid | -- | -- | 71.13% | 60.50% | 55.43% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -32.35% | -36.81% | -13.41% |
| Foreign Exchange rate Adjustments | -- | -- | -148.42% | -139.11% | 319.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | 274.51% | -152.97% | 101.01% |